Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Caris Life Sciences (CAI) Equity Average (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Equity Average data on record, last reported at $527.8 million in Q4 2025.

  • For Q4 2025, Equity Average rose 121.37% year-over-year to $527.8 million; the TTM value through Dec 2025 reached $527.8 million, up 121.37%, while the annual FY2025 figure was -$960.8 million, 58.62% up from the prior year.
  • Equity Average reached $527.8 million in Q4 2025 per CAI's latest filing, up from $465.6 million in the prior quarter.
  • Across five years, Equity Average topped out at $527.8 million in Q4 2025 and bottomed at -$2.5 billion in Q4 2024.